MIT gene editing spinout launches with $213M to write the 'final chapter in genomic medicine'
Summary
When John Finn agreed to meet two young MIT sci\xaden\xadtists in the sum\xadmer of 2021, they ex\xadplained how they had de\xadvel\xadoped a twist on CRISPR gene edit\xading tech\xadnol\xado\xadgy, one that could drag and drop large se\xadquences of DNA, thou\xadsands of let\xadters long, in\xadto pre\xadcise lo\xadca\xadtions of the genome.At the time, gene edit\xading tools were best for mak\xading small tweaks to DNA. The MIT sci\xaden\xadtists, Omar Abu\xaddayyeh and Jonathan Gooten\xadberg, said their in\xadven\xadtion could up\xadload whole genes. And un\xadlike vi\xadral vec\xadtor-based gene ther\xada\xadpies, it could con\xadtrol ex\xadact\xadly where those genes go.Unlock this article instantly by becoming a free subscriber. Youll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.